Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: J Neurooncol. 2020 Feb 3;147(1):195–203. doi: 10.1007/s11060-020-03415-w

Fig 2.

Fig 2

Distribution of first neurologic symptom category improvement by RT dose and dexamethasone dose during RT with smoothed median dose (red line) and dose distribution (black dots) (far right).